Director at Innovex International (INVX) awarded 5,465 common shares in Form 4

Rhea-AI Filing Summary

Innovex International director Sedita Angie reported a stock grant. On this Form 4, Sedita received 5,465 shares of Innovex International, Inc. common stock as a grant or award at no cost. After this acquisition, Sedita directly holds a total of 29,881 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sedita Angie

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,465	$0.00	--

Holdings After Transaction: Common Stock — 29,881 shares (Direct)

Footnotes (1)

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sedita Angie

(Last) (First) (Middle)

C/O INNOVEX INTERNATIONAL, INC.

19120 KENSWICK DRIVE

(Street)

HUMBLE TX 77338

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		5,465	A	$0	29,881	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Matt Steinheider, as Attorney-in-Fact for Angie Sedita	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Innovex International (INVX) report on this Form 4?

Innovex International reported that director Sedita Angie received a grant of 5,465 shares of common stock. The transaction was coded as an award acquisition and involved no cash price per share, reflecting an equity-based compensation event rather than an open-market trade.

How many Innovex International (INVX) shares does Sedita Angie own after this transaction?

After the reported grant, director Sedita Angie directly owns 29,881 shares of Innovex International common stock. This total reflects the new 5,465-share award added to her existing holdings, as disclosed in the Form 4’s post-transaction ownership figure.

Was cash paid for the Innovex International (INVX) shares granted to Sedita Angie?

No cash was paid for these Innovex International shares. The Form 4 shows a transaction price per share of 0.0000, indicating the 5,465 shares were received as a grant or award under an equity compensation arrangement rather than purchased on the open market.

What does transaction code "A" mean in the Innovex International (INVX) Form 4?

Transaction code “A” on the Form 4 indicates a grant, award, or other acquisition of securities. In this Innovex International filing, it describes the 5,465-share common stock grant to director Sedita Angie, categorized as a non-derivative equity award acquisition.

Is the Innovex International (INVX) Form 4 transaction a buy or a grant?

The Innovex International Form 4 reflects a grant, not an open-market buy. The filing labels the event as a grant or award acquisition, with 5,465 common shares received at a price of 0.0000 per share, consistent with standard equity compensation to a director.

What type of security did Sedita Angie receive from Innovex International (INVX)?

Sedita Angie received Innovex International common stock. The Form 4 specifies that 5,465 shares of common stock were awarded as a non-derivative grant, increasing her directly held common share position to a reported total of 29,881 shares after the transaction.